Cargando…

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model

BACKGROUND: Nipah virus (NiV) causes recurrent outbreaks of lethal respiratory and neurological disease in Southeast Asia. The World Health Organization considers the development of an effective vaccine against NiV a priority. METHODS: We produced two NiV vaccine candidates using the licensed VSV-EB...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Wit, Emmie, Feldmann, Friederike, Cronin, Jacqueline, Goldin, Kerry, Mercado-Hernandez, Reinaldo, Williamson, Brandi N., Meade-White, Kimberly, Okumura, Atsushi, Callison, Julie, Weatherman, Sarah, Rosenke, Rebecca, Avanzato, Victoria A., Lovaglio, Jamie, Scott, Dana P., Marzi, Andrea, Feldmann, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763366/ https://www.ncbi.nlm.nih.gov/pubmed/36508878 http://dx.doi.org/10.1016/j.ebiom.2022.104405

Ejemplares similares

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
por: Bhatia, Bharti, et al.
Publicado: (2023)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Development of a nonhuman primate model for mammalian bornavirus infection
por: Schlottau, Kore, et al.
Publicado: (2022)

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
por: Marzi, Andrea, et al.
Publicado: (2019)

UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, Kyle, et al.
Publicado: (2021)

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
por: O'Donnell, Kyle L., et al.
Publicado: (2023)

Favipiravir (T-705) Protects IFNAR(−/−) Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
por: Matz, Keesha, et al.
Publicado: (2021)

A VSV-based Zika virus vaccine protects mice from lethal challenge
por: Emanuel, Jackson, et al.
Publicado: (2018)

Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters
por: Baseler, Laura, et al.
Publicado: (2016)

ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
por: Marzi, Andrea, et al.
Publicado: (2021)

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, K., et al.
Publicado: (2021)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
por: Monath, Thomas P., et al.
Publicado: (2023)

Nipah Virus Transmission in a Hamster Model
por: de Wit, Emmie, et al.
Publicado: (2011)

Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021)

Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route
por: Munster, Vincent J., et al.
Publicado: (2012)

Foodborne Transmission of Nipah Virus in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2014)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2
por: Munster, Vincent J., et al.
Publicado: (2020)

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
por: Munster, Vincent J., et al.
Publicado: (2020)

Nipah Virus Efficiently Replicates in Human Smooth Muscle Cells without Cytopathic Effect
por: DeBuysscher, Blair L., et al.
Publicado: (2021)

Comparison of the Pathogenicity of Nipah Virus Isolates from Bangladesh and Malaysia in the Syrian Hamster
por: DeBuysscher, Blair L., et al.
Publicado: (2013)

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
por: Rosenke, Kyle, et al.
Publicado: (2020)

Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques
por: Rosenke, Kyle, et al.
Publicado: (2023)

Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques
por: Rosenke, Kyle, et al.
Publicado: (2022)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

Domestic Pig Unlikely Reservoir for MERS-CoV
por: de Wit, Emmie, et al.
Publicado: (2017)

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013)

A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus
por: Bhatia, Bharti, et al.
Publicado: (2021)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
por: Marzi, Andrea, et al.
Publicado: (2012)

Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys
por: Speranza, Emily, et al.
Publicado: (2021)

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
por: Furuyama, Wakako, et al.
Publicado: (2021)

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
por: Hansen, Frederick, et al.
Publicado: (2022)

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine
por: Furuyama, Wakako, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ht9cckq491ps75dif021giim9q